Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3846494

COc1ccc(N2CCN(c3ncnc4ccc(-c5cn[nH]c5)cc34)CC2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.53
MTNR1B P49286 2/20 0.49
CLK4 Q9HAZ1 6/20 0.48
CYP3A4 P08684 5/20 0.48
USP2 O75604 4/20 0.48
CYP1A2 P05177 3/20 0.48
CYP2C19 P33261 3/20 0.48
HIF1A Q16665 3/20 0.48
LMNA P02545 3/20 0.48
CYP2D6 P10635 3/20 0.48
MAPK1 P28482 3/20 0.48
ALDH1A1 P00352 2/20 0.48
HSD17B10 Q99714 3/20 0.48
TSHR P16473 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
PDGFRB P09619 2/20 0.45
ACHE P22303 3/20 0.44
BACE1 P56817 3/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3846051 0.92 CYP1A2 (0.56) AKT1MTNR1BCLK4CYP3A4USP2
Trifluoroacetic Acid SCHEMBL3855290 0.91 AKT1 (0.54) AKT1CLK4CYP3A4USP2CYP1A2
Trifluoroacetic Acid SCHEMBL3845878 0.90 AKT1 (0.56) AKT1CLK4CYP3A4USP2CYP1A2
Trifluoroacetic Acid SCHEMBL3847292 0.90 AKT1 (0.65) AKT1CLK4CYP3A4USP2CYP1A2
Trifluoroacetic Acid SCHEMBL3851562 0.89 AKT1 (0.55) AKT1CLK4CYP3A4USP2CYP1A2
Trifluoroacetic Acid SCHEMBL3851492 0.88 AKT1 (0.51) AKT1CLK4CYP3A4USP2CYP1A2
Trifluoroacetic Acid SCHEMBL3854823 0.87 AKT1 (0.52) AKT1CLK4CYP3A4USP2CYP1A2
Trifluoroacetic Acid SCHEMBL5852383 0.87 AKT1 (0.55) AKT1CLK4CYP3A4USP2CYP1A2
Trifluoroacetic Acid SCHEMBL3849021 0.85 AKT1 (0.52) AKT1CLK4CYP3A4USP2CYP1A2
Trifluoroacetic Acid SCHEMBL3856624 0.85 AKT1 (0.52) AKT1CLK4CYP3A4USP2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed